HoldsUp

Ford Brewer

Ford Brewer is a health commentator and researcher focusing on cardiovascular health. He produces content examining topics such as atherosclerosis, arterial plaque, and the physiological effects of compounds like taurine. His published academic research addresses early multidrug treatment strategies for high-risk ambulatory SARS-CoV-2 (COVID-19) infections.

36 claims checked on air: 4 context 1 contradicted 1 overstated 26 supported 4 unverified

What they said on air - context

0:50:58needs contextmoderateThe Shocking Truth About Taurine and Arterial Plaque: New Ev

Intense exercise is contraindicated for individuals with significant aortic stenosis, pontine strokes, or significant aortic aneurysms.

"One is what this person brought up. Evidently, they know somebody that has this problem: aortic severe, significant severe aortic stenosis. A pontine stroke... people with a pontine stroke can't and should not be doing intense exercise. And people with an aortic aneurysm, a significant one." (said at 0:50:58)

Cardiovascular clinical guidelines clearly contraindicate intense or vigorous exercise in individuals with severe aortic stenosis and significant aortic aneurysms due to the substantial risk of hemodynamic collapse, sudden cardiac death, or aortic dissection/rupture from acute blood pressure surges. For pontine stroke, intense exercise is generally clinically unfeasible or restricted due to severe motor deficits, ataxia, cranial neuropathies, or autonomic dysregulation, though tailored rehabilitation and moderate exercise are standard post-stroke therapies rather than intense exercise being a unique standalone physiological contraindication.

0:56:50needs contexthighThe Shocking Truth About Taurine and Arterial Plaque: New Ev

Standard clinical guidelines recommend against initiating or continuing aspirin for primary prevention once patients reach their 80s due to increased bleeding risk.

"and the standard recommendation is not to take aspirin once you hit your 80s because of the increased risk for a bleed." (said at 0:56:50)

Standard clinical guidelines recommend against initiating low-dose aspirin for primary prevention starting at age 60 or 70 (rather than specifically age 80), due to increased bleeding risks without clear net clinical benefit. For example, the United States Preventive Services Task Force (USPSTF) 2022 guidelines recommend against initiating low-dose aspirin for primary prevention of cardiovascular disease in adults aged 60 years or older. Similarly, the 2019 ACC/AHA guidelines reserve primary prevention aspirin consideration for select patients aged 40 to 70 years at high cardiovascular risk and low bleeding risk. While the host's statement accurately captures the rationale (increased bleeding risk and lack of net benefit in older age groups) and the recommendation against taking primary prevention aspirin in one's 80s, the official age cutoff in guidelines is younger (starting at age 60 or 70).

0:58:34needs contextmoderateThe Shocking Truth About Taurine and Arterial Plaque: New Ev

The Honda study utilized optical character recognition on carotid ultrasound images and showed that people with little to no soft plaque have very low rates of heart attack and stroke events.

"The Honda study that we talk about a lot in this space actually used optical character recognition. They didn't even use a human at all to interpret it. And they showed that yeah, people that have little to no soft plaque just don't have heart attack and stroke events." (said at 0:58:34)

The speaker is referring to the 2004 study by Honda et al. in the Journal of the American College of Cardiology (PMID 15063426), which investigated 286 patients with coronary artery disease (CAD) followed prospectively for up to 30 months. The study demonstrated that patients with echolucent ('soft', lipid-rich) carotid plaques had significantly higher rates of future coronary complications than those without echolucent plaque (odds ratio 7.0, 95% CI 2.3–21.4). However, the automated quantitative analysis used was ultrasound integrated backscatter (IBS) acoustic densitometry, not 'optical character recognition' (OCR), which is text-recognition technology.

1:00:15needs contextmoderateThe Shocking Truth About Taurine and Arterial Plaque: New Ev

Arterial plaque formation commonly begins to appear in individuals when their hemoglobin A1C reaches approximately 5.8%.

"Actually, an A1C of 5.8 is not great. That's about where we start to see a lot of people forming plaque." (said at 1:00:15)

Large observational imaging studies demonstrate that the risk and burden of subclinical arterial plaque increase significantly in the prediabetic range, including around an HbA1c of 5.7% to 5.8%. In the Progression of Early Subclinical Atherosclerosis (PESA) cohort of 3,973 middle-aged individuals without diabetes, an HbA1c of 5.7% to 5.8% was associated with an 80% increased odds of multiterritorial subclinical atherosclerosis compared to an HbA1c of 4.8% or lower. However, atherosclerosis does not abruptly begin at 5.8%; plaque formation is a continuous process that was significantly elevated even at levels of 5.5% to 5.6% and is driven by multiple cumulative cardiovascular risk factors beyond glycemia alone.

Fact-checked episodes

Publications